Pepcid and Drisdol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Drisdol (ergocalciferol). Common drug interactions include cellulitis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Drisdol. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Drisdol?

Drisdol has active ingredients of ergocalciferol. It is often used in vitamin d. eHealthMe is studying from 1,740 Drisdol users. Check the latest studies of Drisdol.



On Jul, 26, 2026

70 people who take Pepcid and Drisdol together, and have interactions are studied.

Pepcid and Drisdol drug interactions.

What are the common drug interactions of Pepcid and Drisdol, by gender? *:

female:

  1. Cellulitis (infection under the skin)
  2. Chest discomfort
  3. Dehydration (dryness resulting from the removal of water)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Peripheral swelling
  6. Renal failure (kidney dysfunction)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Tinnitus (a ringing in the ears)
  9. Dyspnoea (difficult or laboured respiration)
  10. Essential hypertension (primary hypertension)

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Leukocytosis (increased white blood cells)
  4. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Pain
  7. Renal tubular necrosis (death of kidney tubules)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Asthenia (weakness)
  10. Full blood count decreased

What are the common drug interactions of Pepcid and Drisdol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Nausea (feeling of having an urge to vomit)
  3. Chest discomfort
  4. Diarrhoea
  5. Headache (pain in head)
  6. Myalgia (muscle pain)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Tinnitus (a ringing in the ears)
  10. Pain

40-49:

  1. Renal failure (kidney dysfunction)
  2. Cellulitis (infection under the skin)
  3. Renal injury (kidney injury)
  4. Abdominal pain
  5. Blindness
  6. Blood alkaline phosphatase increased
  7. Blood potassium decreased
  8. Catheter site erythema (redness of skin at catheter site)
  9. Catheter site pruritus (itching at the site)
  10. Chest pain

50-59:

  1. Emotional distress
  2. Pain
  3. Stress
  4. Angioimmunoblastic t-cell lymphoma stage iv (mature t-cell cancer of the blood or lymph vessel-stage iv)
  5. Calciphylaxis (is a syndrome with vascular calcium accumulation)
  6. Drug hypersensitivity
  7. Failure to thrive (inadequate weight gain and physical growth in children)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Insomnia (sleeplessness)
  10. Localised oedema (fluid retention in a particular part of the body)

60+:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Renal tubular necrosis (death of kidney tubules)
  3. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  4. Cellulitis (infection under the skin)
  5. Death
  6. Dehydration (dryness resulting from the removal of water)
  7. Essential hypertension (primary hypertension)
  8. Injection site pain
  9. Muscle rupture (tear in muscle)
  10. Peripheral swelling

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 20 people, 28.57%
  2. Stress And Anxiety: 15 people, 21.43%
  3. Pain: 13 people, 18.57%
  4. Constipation: 12 people, 17.14%
  5. High Blood Pressure: 11 people, 15.71%
  6. Depression: 10 people, 14.29%
  7. Muscle Spasms (muscle contraction): 10 people, 14.29%
  8. Nausea And Vomiting: 9 people, 12.86%
  9. Multiple Myeloma (cancer of the plasma cells): 8 people, 11.43%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Drisdol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid and Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Drisdol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on famotidine and ergocalciferol (the active ingredients of Pepcid and Drisdol, respectively), and Pepcid and Drisdol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: